245 related articles for article (PubMed ID: 28082020)
21. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
[TBL] [Abstract][Full Text] [Related]
22. Increased Expression of Lysine-Specific Demethylase 5B (KDM5B) Promotes Tumor Cell Growth in Hep3B Cells and is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma.
Gong J; Yan S; Yu H; Zhang W; Zhang D
Med Sci Monit; 2018 Oct; 24():7586-7594. PubMed ID: 30353907
[TBL] [Abstract][Full Text] [Related]
23. MiR-628-5p Inhibits Cervical Carcinoma Proliferation and Promotes Apoptosis by Targeting VEGF.
Wu X; Lei J; Zhou B; Sun Q; Gao Y; Shi F; Yang W
Am J Med Sci; 2021 Apr; 361(4):499-508. PubMed ID: 33775424
[TBL] [Abstract][Full Text] [Related]
24. MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.
Xu LJ; Duan Y; Wang P; Yin HQ
Biochem Biophys Res Commun; 2018 Sep; 503(2):556-563. PubMed ID: 29807015
[TBL] [Abstract][Full Text] [Related]
25. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.
He D; Miao H; Xu Y; Xiong L; Wang Y; Xiang H; Zhang H; Zhang Z
PLoS One; 2014; 9(11):e112930. PubMed ID: 25411783
[TBL] [Abstract][Full Text] [Related]
26. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA‑424 suppresses the proliferation of hemangioma‑derived endothelial cells by targeting VEGFR‑2.
Fei Z; Qiu M; Qi X; Dai Y; Wang S; Quan Z; Liu Y; Ou J
Mol Med Rep; 2018 Oct; 18(4):4065-4071. PubMed ID: 30132564
[TBL] [Abstract][Full Text] [Related]
29. Identification of the upstream regulators of KDM5B in gastric cancer.
Zhao LF; Qi FY; Zhang JG; Pang JR; Ren HM; Shen DD; Zhao LJ; Qi L; Liu HM; Zheng YC
Life Sci; 2022 Jun; 298():120458. PubMed ID: 35248525
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
Pang RT; Leung CO; Ye TM; Liu W; Chiu PC; Lam KK; Lee KF; Yeung WS
Carcinogenesis; 2010 Jun; 31(6):1037-44. PubMed ID: 20351093
[TBL] [Abstract][Full Text] [Related]
31. CUX2/KDM5B/SOX17 Axis Affects the Occurrence and Development of Breast Cancer.
Li L; Zhu G; Tan K; Jiang L; Li Y; Zhu X; Lin Z; Zhang X; Chen J; Ma C
Endocrinology; 2022 Sep; 163(9):. PubMed ID: 35881915
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer.
Guan H; Dai Z; Ma Y; Wang Z; Liu X; Wang X
Int J Mol Med; 2016 Jun; 37(6):1643-51. PubMed ID: 27082308
[TBL] [Abstract][Full Text] [Related]
33. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer.
Hui Z; Yiling C; Wenting Y; XuQun H; ChuanYi Z; Hui L
FEBS Lett; 2015 Mar; 589(7):812-21. PubMed ID: 25725194
[TBL] [Abstract][Full Text] [Related]
34. MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells.
Wei Q; Li YX; Liu M; Li X; Tang H
IUBMB Life; 2012 Aug; 64(8):697-704. PubMed ID: 22730212
[TBL] [Abstract][Full Text] [Related]
35. microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4.
Li J; Hu L; Tian C; Lu F; Wu J; Liu L
BMC Mol Biol; 2015 Dec; 16():24. PubMed ID: 26715362
[TBL] [Abstract][Full Text] [Related]
36. MiR-17-5p promotes cervical cancer cell proliferation and metastasis by targeting transforming growth factor-β receptor 2.
Cai N; Hu L; Xie Y; Gao JH; Zhai W; Wang L; Jin QJ; Qin CY; Qiang R
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1899-1906. PubMed ID: 29687841
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-455-5p exerts inhibitory effect in cervical carcinoma through targeting S1PR1 and blocking mTOR pathway.
Hu D; Sun S; Wang Y
Arch Gynecol Obstet; 2020 May; 301(5):1307-1315. PubMed ID: 32303890
[TBL] [Abstract][Full Text] [Related]
38. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.
Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z
Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723
[TBL] [Abstract][Full Text] [Related]
39. Co-targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis.
Brown LK; Kanagasabai T; Li G; Celada SI; Rumph JT; Adunyah SE; Stewart LV; Chen Z
Prostate; 2024 Jun; 84(9):877-887. PubMed ID: 38605532
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.
Liu F; Gong J; Huang W; Wang Z; Wang M; Yang J; Wu C; Wu Z; Han B
Oncogene; 2014 Oct; 33(40):4813-22. PubMed ID: 24166509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
